Antibacterial properties of quindoxin: a new growth-promoting agent.
D000693:Anaerobiosis; D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D002645:Chickens; D003013:Clostridium / Q000187:drug effects / Q000254:growth & development; D003497:Cyclic N-Oxides / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D006128:Growth / Q000187:drug effects*; D010118:Oxytetracycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D011810:Quinoxalines / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects / Q000254:growth & development; D014769:Virginiamycin / Q000494:pharmacology
D003497:Cyclic N-Oxides; D011810:Quinoxalines; D014769:Virginiamycin; D001414:Bacitracin; C003282:quindoxin; D010400:Penicillin G; D010118:Oxytetracycline